About Theorem Clinical Research
Theorem Clinical Research is a Healthcare company based in King Of Prussia (United States) founded in 1985, and was acquired by Chiltern International in August 2015. Clinical development services for biopharma and medical devices are provided. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Celgene, Syneos Health and Medelis WCCT Global; 2 of its 3 listed competitors have raised funding.
Company details
The company was offering clinical development services, such as clinical trial management, clinical monitoring, clinical quality assurance, and medical monitoring and clinical analytics services, including clinical data management, medical writing, and biometrics services. In addition, the company offered clinical support services, such as TrialShare, a secure study-and project-specific Web portal that enables data sharing and collaboration; Theorem Clinical Research Inc. had strategic alliances with companies like Charles River, Decision Driver Analytics, Biomedical Systems, Ximedica etc, . It had expertise in development of medical devices and diagnostics, and also in clinical analytics and clinical supplies. It was acquired by Chiltern, a UK based CRO, in September 2015.
- Headquarters King Of Prussia, United States
- Stage Acquired
- SectorsHealthcare
- Website theoremclinical.com
- Social LinkedIn X Facebook
- Acquired by Chiltern International (Aug 2015)
- Investors
- Acquired byChiltern International
(Aug 2015)
Investors in Theorem Clinical Research
Theorem Clinical Research has secured backing from 1 investor. Prominent investors backing the company include Chiltern International.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Full service CRO with expertise in oncology related development services | 1982 | chiltern.com | Berkshire County, United States |
Investor details for Theorem Clinical Research
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Theorem Clinical Research
2 dated milestones of Theorem Clinical Research across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Theorem Clinical Research is founded.
- Exit Acquired by Chiltern International.
Competitors of Theorem Clinical Research
Theorem Clinical Research has 3 listed competitors in our database, 2 of them funded. They include Celgene, Syneos Health and Medelis WCCT Global.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| celgene.com | 1986 | Summit, United States | $45M | 4,891 | Therapies for cancer and inflammatory diseases are developed. | |
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| wcct.com | 1998 | Cypress, United States | $17M | 229 | Full-service CRO expertise in influenza and oncology research is offered. |
Detailed competitors of Theorem Clinical Research
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Theorem Clinical Research
Websites that share an audience with Theorem Clinical Research (theoremclinical.com).
Websites whose visitors overlap most with Theorem Clinical Research. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aptivsolutions.com | 100% | View details | |||
| premier-research.com | 96% | 39.9K | #825,378 | View details | |
| indeed.com | 69% | 416.4M | #70 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Theorem Clinical Research (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Theorem Clinical Research
Theorem Clinical Research was founded in 1985.
Theorem Clinical Research is headquartered in King Of Prussia, United States. It is registered at King Of Prussia, Pennsylvania, United States.
The company was offering clinical development services, such as clinical trial management, clinical monitoring, clinical quality assurance, and medical monitoring and clinical analytics services, including clinical data management, medical writing, and biometrics services. In addition, the company offered clinical support services, such as TrialShare, a secure study-and project-specific Web portal that enables data sharing and collaboration; Theorem Clinical Research Inc. had strategic alliances with companies like Charles River, Decision Driver Analytics, Biomedical Systems, Ximedica etc, . It had expertise in development of medical devices and diagnostics, and also in clinical analytics and clinical supplies. It was acquired by Chiltern, a UK based CRO, in September 2015.
Theorem Clinical Research's top competitors include Syneos Health, Medelis WCCT Global and Celgene.
Theorem Clinical Research has 1 investor. Key investors include Chiltern International.
Yes. Theorem Clinical Research was acquired by Chiltern International in August 2015.
